Patents Pending
Not commercially available in the US
NPseal™ for Practitioners
Enabling prophylactic use of NPWT for surgical patients
Surgical Site Infection (SSI) has been identified as a high global epidemiological burden1. Prophylactic use of Negative Pressure Wound Therapy (NPWT) on closed incisional wounds has been shown to reduce SSI by over 50%2.
We created NPseal™ to address this clinical need. NPseal is an elegant, easy-to-use Negative Pressure Wound Therapy (NPWT) surgical dressing specifically designed to enable prophylactic use on small closed surgical wounds.
Introducing the simple, innovative and cost-effective solution using NPWT
Key to NPseal’s design is a proprietary pinch pump. The integrated pump is made from soft, pliable material that effectively pumps air out of the wound space and establishes a negative pressure of -75 to -125 mmHg. The simple pinch process also makes it easy for patients to maintain NPseal therapy at home.
Healthcare Associated Infections (HAI) add almost $10 billion in cost to US healthcare.
More than $3.2 billion of annual HAI costs are from surgical site infections (SSI).
NPseal makes Negative Pressure Wound therapy more accessible to help reduce surgical site infections.
By increasing access to NPWT for surgical patients, NPseal has the potential to improve patient care while generating considerable savings for the health care system.
SSI remains one of the most feared complications of surgery. In addition to financial costs, SSI results in longer hospitalizations, increased morbidity, and increased mortality.
1Allegranzi et al., New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective, Lancet Infect Dis 2016; 16: e288–303
2Strugula et al., Meta-Analysis of Comparative Trials Evaluating a Prophylactic Single-Use Negative Pressure Wound Therapy System for the Prevention of Surgical Site Complications, Surgical Infections Volume 18, Number 7, 2017